News | January 26, 2024
Roche inaugurates new campus for Digital Centre of Excellence in Pune
The new campus has been designed as an employee-centred experience and ecosystem zone
The new campus has been designed as an employee-centred experience and ecosystem zone
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Automated parallel capillary electrophoresis system simplifies protein analysis
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
Inducts advanced AI-Powered 24x7 remote patient monitoring system
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Submission based on positive results from global phase 3 study demonstrating overall survival benefit of TIVDAK over chemotherapy
TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union
Subscribe To Our Newsletter & Stay Updated
